The Patent Finder

Pledpharma AB

Also on record
Records under this name other than patents Pledpharma AB holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.

Showing 1 to 7 of 7 · Back to Pledpharma AB

PatentTitleStatus Expires Confidence
US 10,688,087Pharmaceutical compositions and therapeutic methods employing a combination of a manganese complex compound and a non-manganese complex form of the compound
Formerly held
In force
 · From the USPTO record
In forceFrom the USPTO record
US 9,187,509Calmangafodipir, a New Chemical Entity, and Other Mixed Metal Complexes, Methods of Preparation, Compositions, and Methods of Treatment
Formerly held
In force
 · High confidence
In forceHigh confidence
US 9,597,334Calmangafodipir, a New Chemical Entity, and Other Mixed Metal Complexes, Methods of Preparation, Compositions, and Methods of Treatment
Formerly held
In force
 · High confidence
In forceHigh confidence
US 10,111,893Calmangafodipir, a New Chemical Entity, and Other Mixed Metal Complexes, Methods of Preparation, Compositions, and Methods of Treatment
Formerly held
In force
 · High confidence
In forceHigh confidence
US 11,260,060Methods and formulations for treatment of and/or protection against acute liver failure and other hepatotoxic conditions
Formerly held
In force
 · From the USPTO record
In forceFrom the USPTO record
US 8,633,174Compounds for use in the treatment of cancer
Formerly held
Lapsed on the fee record
Ended Jan 21, 2026 · From the USPTO record
Lapsed on the fee recordEnded Jan 21, 2026From the USPTO record
US 8,377,969Compounds for use in the treatment of cancer
Formerly held
Lapsed on the fee record
Ended Feb 19, 2025 · From the USPTO record
Lapsed on the fee recordEnded Feb 19, 2025From the USPTO record
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited